title: The new dietary fats in health and disease.
abstract: Lipids are an integral part of the routine diet of patients and the general public. In this article, the physiologic properties of various dietary lipids are reviewed, beginning with those most commonly consumed-the long-chain triglycerides (LCTs) and extending to those with special purposes: the short- and medium-chain triglycerides. The nutritional dietary management of patients typically includes physical mixtures of lipids. Recently, structured triglycerides (STs), which combine advantages from conventional fats with those of special purposes, have become available. STs are currently developed by interesterifying a mixture of conventional fats and oils, usually with medium-chain triglycerides, to achieve a specific fatty acid profile. This results in a triglyceride containing combinations of short-, medium-, and long-chain fatty acids on a single glycerol backbone. They have unique chemical, physical, or physiologic properties that are not observed by simply blending mixtures of the starting fats and oils. A number of STs are under intense laboratory and clinical investigation in models of cancer, burns, and immune dysfunction. Much interest in the fatty acids resides in the sn-2 position on the glycerol molecule. This is because the fatty acid in the sn-2 position of triglycerides is preferentially absorbed as the 2-monoglyceride and serves as the template for reesterification by intestinal cells to re-form triglycerides. The sn-2 fatty acids are also preferentially preserved as components of chylomicrons and very-low-density lipoprotein particles for ultimate incorporation in tissue membranes. Technology is evolving to create STs with a selected fatty acid in this sn-2 position. For instance, incorporating linoleic, arachidonic, or eicosapentaenoic acid at the sn-2 position is being evaluated for the specific objective of modulating serum cholesterol concentrations and essential fatty acid absorption (a review of this work is included).
authors.affiliation: Harvard Medical School, Boston, Mass., USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: Bell
authors.forename: D
authors.initials: D
authors.lastname: Bradley
authors.forename: R A
authors.initials: RA
authors.lastname: Forse
authors.forename: B R
authors.initials: BR
authors.lastname: Bistrian
mesh_terms: D000042:Absorption; D000818:Animals; D004041:Dietary Fats / Q000008:administration & dosage / Q000032:analysis*; D004195:Disease Models, Animal; D004750:Enteral Nutrition; D005227:Fatty Acids / Q000737:chemistry / Q000493:pharmacokinetics; D005526:Food, Formulated; D006801:Humans; D014280:Triglycerides / Q000737:chemistry / Q000493:pharmacokinetics / Q000502:physiology*
chemical_list: D004041:Dietary Fats; D005227:Fatty Acids; D014280:Triglycerides